Biologic Patent Protection: When Biosimilars Can Enter the U.S. Market
Biologic patent protection in the U.S. gives drugmakers 12 years of exclusivity before biosimilars can enter, delaying competition and keeping prices high. Learn how patents, litigation, and complex manufacturing block affordable alternatives.
Continue reading...